| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 43 |
| 1 | METHOTREXATE SODIUM | 40 |
| 2 | METHOTREXATE | 37 |
| 3 | PACLITAXEL | 33 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 32 |
| 5 | ASPIRIN | 29 |
| 6 | ASPIRIN 325 MG | 29 |
| 7 | ASPIRIN 81 MG | 29 |
| 8 | CARBOPLATIN | 29 |
| 9 | BEVACIZUMAB | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRAPARIB | 43 | 0.0019 |
| 1 | OLAPARIB | 23 | 0.0011 |
| 2 | POLATUZUMAB VEDOTIN | 8 | 0.0008 |
| 3 | FULVESTRANT | 19 | 0.0006 |
| 4 | ERGOCALCIFEROL | 13 | 0.0004 |
| 5 | PACLITAXEL | 33 | 0.0003 |
| 6 | LETROZOLE | 18 | 0.0003 |
| 7 | RIBOCICLIB | 9 | 0.0003 |
| 8 | LETROZOLE TABLETS | 12 | 0.0002 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 8 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 23 | 0.0011 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 3 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Estrogen Receptor Antagonist [EPC] | 19 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 29 | 0.0003 |
| 8 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 9 | Aromatase Inhibitor [EPC] | 27 | 0.0002 |